Dutch Electrical Stock News

Wolters Kluwer (ENXTAM:WKL) has tied two recent moves to its long running digital push: expanding its Libra legal AI workspace in Germany and appointing Tejas Shah as Executive Vice President, Chief Strategy & Innovation Officer. See our latest analysis for Wolters Kluwer. These AI focused moves come after a tougher spell for investors, with a 24% 3 month share price decline and a 52.52% 1 year total shareholder return loss. However, the 5 year total shareholder return of 23.36% still...

Fugro N.V. ( AMS:FUR ) shareholders would be excited to see that the share price has had a great month, posting a 30...

SBM Offshore N.V. ( AMS:SBMO ) shares have continued their recent momentum with a 26% gain in the last month alone. The...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Heineken N.V. recently confirmed that it has completed the first €750 million tranche of its €1.50 billion share buyback programme, repurchasing a total of 10,572,215 shares, including 226 shares acquired from Heineken Holding N.V. between 19 and 23 January 2026. This milestone highlights Heineken’s current capital allocation approach, using a large-scale, phased repurchase plan while maintaining transparency through weekly progress updates. We will now examine how the completion of this...

Jefferies recently initiated coverage on ABN AMRO Bank with a “hold” rating, highlighting the lender’s capital position, earnings outlook, and Dutch mortgage exposure while noting that its dividend yield is supported by capital buffers and capital ratios above regulatory requirements. The broker’s view that both ABN AMRO and ING are positioned to return capital to shareholders underscores how robust regulatory capital levels can underpin income-focused investment cases. We’ll now examine how...

If you are wondering whether ASML Holding's current share price reflects its true worth, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at €1,217.60, with returns of 6.8% over 7 days, 35.4% over 30 days, 23.5% year to date, 90.1% over 1 year, 107.7% over 3 years and 178.5% over 5 years. These figures naturally raise questions for you about what is already priced in. Recent attention around ASML has centered on its role in the...

Adyen (ENXTAM:ADYEN) has been in focus after announcing a collaboration with Forage to enable SNAP EBT payments for its U.S. merchants, expanding its reach in food, beverage, and grocery payments. See our latest analysis for Adyen. These new partnerships in food, grocery, and platform payments come as Adyen’s share price sits at €1,393.60, with a 7 day share price return of 1.65% but a 1 year total shareholder return of 7.32% decline, suggesting recent momentum has been modest while longer...

If you are wondering whether Koninklijke Philips shares are offering fair value at around €24.76, the key is to understand how that price compares with different measures of worth. Over the last month the stock has returned 8.9%, with a 7.1% return year to date, while the 1 year return of a 0.5% decline and the 5 year return of a 36.8% decline sit alongside a very large 3 year gain of 67.3%. Recent coverage around Philips has focused on ongoing business developments and risk considerations,...

The European markets have recently faced a downturn, with the pan-European STOXX Europe 600 Index and major national indices like France’s CAC 40 and Germany’s DAX experiencing declines amid renewed trade and geopolitical uncertainties. Despite these challenges, investors continue to explore opportunities beyond the well-known names, turning their attention to penny stocks. While often associated with smaller or newer companies, penny stocks can still provide significant value when backed by...

There wouldn't be many who think Alumexx N.V.'s ( AMS:ALX ) price-to-sales (or "P/S") ratio of 0.5x is worth a mention...

Why Pharming Group’s latest revenue update is getting attention Pharming Group (ENXTAM:PHARM) has drawn fresh investor interest after reporting preliminary 2025 revenues about 27% above its own guidance, alongside a 2026 sales outlook tied to Joenja and upcoming clinical trial read outs. See our latest analysis for Pharming Group. The preliminary 2025 revenue update appears to have come on the back of building momentum in the share price, with a 30 day share price return of 18.82% and a 90...

Earlier this month, ASM International reported an upbeat early Q4 2025 update, indicating that Q1 2026 revenue at constant currencies should rise healthily, supported by demand from leading-edge foundry and logic customers. Berenberg responded by upgrading its medium-term forecasts for ASM International’s sales, EBIT, and EPS, highlighting the importance of steadier capital spending signals from major customers such as TSMC and Intel for the company’s order outlook. We will now examine how...

AMG Critical Materials N.V. recently announced that its subsidiary AMG LIVA will install a Hybrid Energy Storage System, combining lithium‑ion and vanadium redox flow batteries with AI-driven controls, at Aramco’s solar-integrated Bulk Plant in Tabuk, Saudi Arabia. This project, linked to the planned IK Supercenter recycling hub and local vanadium electrolyte production, underlines AMG’s role in building a fully integrated, lower‑carbon battery materials value chain inside the Kingdom. We’ll...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Universal Music Group recently renewed a multi‑year licensing agreement with NetEase Cloud Music, extending access to UMG’s global catalog in China and adding joint marketing, product innovation, and artist‑centric AI protections. The deal underlines how control over premium content and the rules for using artificial intelligence are becoming central to power in global music streaming. Next, we’ll examine how this expanded NetEase partnership, especially its artist‑centric AI terms,...

In mid-January 2026, ArcelorMittal drew fresh attention as investors reacted to its emphasis on higher-margin, lower-carbon steel products and portfolio optimization, against a backdrop of supportive trade policies and resilient demand outside China. What stands out is how the company’s shift toward cleaner, higher-value steel and divestment of weaker assets is reshaping how analysts and investors view its longer-term prospects. We’ll now examine how this focus on higher-margin, lower-carbon...

Why KPN’s upcoming earnings are drawing fresh attention Koninklijke KPN (ENXTAM:KPN) is back in focus as traders position ahead of its 28 January 2026 earnings announcement, with attention on revenue trends, contract growth, guidance and potential implications for future dividends. See our latest analysis for Koninklijke KPN. At a share price of €3.888, KPN has experienced short term share price pressure, with a 90 day share price return showing a decline of 4.96%, even as the 1 year total...

Market sentiment around ASML Holding (ENXTAM:ASML) has brightened after Taiwan Semiconductor Manufacturing Company outlined a sizable 2026 capital spending plan focused on advanced process technologies, where ASML’s EUV tools play a central role. See our latest analysis for ASML Holding. ASML’s recent momentum has picked up meaningfully, with a 31.1% 1 month share price return contributing to a 69.8% 1 year total shareholder return. This suggests sentiment has improved as chipmakers commit...

CSG (ENXTAM:CSG) grabbed investor attention after its Euronext Amsterdam IPO, with the offering raising about €3.3b and the share price jumping sharply from the €25 issue level on debut. See our latest analysis for CSG. The first day 31.4% share price return from the €25 IPO level to around €32.85 points to strong early momentum, helped by heightened interest in defence contractors and reinforced by the board appointment of Lynn Fordham, which may be seen as adding governance depth. If CSG’s...

Pharming Group recently reported preliminary 2025 revenues that were around 27% higher than the prior year, slightly above its own guidance and easing fears about market share erosion to a rival therapy. The company also highlighted a strong outlook for Joenja/leniolisib and upcoming clinical trial read-outs, suggesting its rare disease portfolio could be an increasingly important growth engine. Next, we’ll examine how this better‑than‑expected revenue performance and confidence around...

Why ING Groep Is Back on Investors’ Radar ING Groep (ENXTAM:INGA) is attracting fresh attention after two developments: the ongoing €1.1b share buyback, which has already retired over 21 million shares, and an upcoming change on its Supervisory Board. See our latest analysis for ING Groep. Those capital returns and governance changes come after a mixed stretch in the market, with a 16.9% 90 day share price return contrasting with modest year to date weakness, while one year and multi year...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you pick the right...

In the last year, multiple insiders have substantially increased their holdings of Akzo Nobel N.V. ( AMS:AKZA ) stock...